Skip to content

Punicic acid alleviates osteoarthritis progression through miR-29a-3p-dependent inhibition of the MAP2K6/p38 MAPK pathway.

Sep 2026 · In vitro Cellular & Developmental Biology-Animal · 0 citations · 34 references
Medicine

TL;DR

It is suggested that PA exerts chondroprotective effects by modulating the miR-29a-3p/MAP2K6/p38 MAPK signaling axis, highlighting its therapeutic potential and supporting the development of miRNA-based therapeutic strategies for OA.

View source

Similar papers

Open access Aug 2026

Secoisolariciresinol diglucoside alleviates inflammatory injury in osteoarthritis chondrocytes through ERBB2-associated JAK2/STAT3 signaling: network pharmacology and experimental validation

Background Cartilage injury is a hallmark of osteoarthritis (OA). erb-B2 receptor tyrosine kinase 2 (ERBB2) has been reported to be involved in mediating the therapeutic effects of polyphenols in orthopedic diseases. This study aimed to investigate the protective effects and underlying mechanisms of action of ERBB2 in...

Hai-Qing Hu, Gaoshan Li, Yang-Xu Wang et al. · 0 citations
Open access Oct 2026

Sinensetin ameliorates osteoarthritis progression by modulating the NF-κB/NLRP3 signaling pathway and suppressing chondrocyte pyroptosis.

Sinensetin (SIN) is a natural flavonoid with potential anti‑inflammatory effects. This study investigated whether SIN ameliorates osteoarthritis (OA) and explored its underlying mechanisms. In vitro, SIN (0.05-1 μg/mL) protected human OA chondrocytes from IL‑1β‑induced viability loss. Transcriptome sequencing and molec...

Zhen-Dong Liu, Rui-Zhou Liu, Hong-Wei Yue et al. · 0 citations
Sep 2026

Ginsenoside Rg3 attenuates osteoarthritis progression by modulating the Nrf2-mediated autophagy pathway.

PURPOSE Osteoarthritis (OA) is a chronic and progressive joint disorder characterized by persistent inflammation, extracellular matrix (ECM) disruption, and chondrocyte apoptosis. This study aimed to investigate the protective effects of ginsenoside Rg3 (Rg3), a natural steroidal saponin from Panax ginseng, on OA and t...

Xin-Jiang Lu, Zhao-Yang Wang, Wei-Feng Hu et al. · 0 citations
Aug 2026

Inhibition of PARP-1 attenuates osteoarthritis progression by suppressing NF-κB signaling and alleviating chondrocyte senescence.

Osteoarthritis (OA) is a prevalent degenerative joint disease characterized by cartilage destruction, inflammation, and chondrocyte senescence, yet no disease-modifying therapies are currently available. Poly(ADP-ribose) polymerase-1 (PARP-1) has been implicated in inflammation and aging, but its role in OA pathogenesi...

Rui Zhang, Lingying Wang, Wen-Bin Pei et al. · 0 citations
Open access Oct 2026

Sesamin Attenuates Interleukin-1β-Induced Inflammation in Human Synovial Cells: Involvement of the Nrf2/HO‑1 Pathway and NLRP3 Expression

Osteoarthritis (OA) is a progressive joint disease characterized by cartilage destruction and is increasingly recognized as involving chronic low-grade inflammation. Synovitis contributes to OA progression through the production of proinflammatory mediators and reactive oxygen species (ROS). Sesamin, a lignan derived f...

Benjawan Wudtiwai, Atitaya Wayupat, Aitthiphon Chongchai et al. · 0 citations
Open access Oct 2026

miR-24 Attenuates IL-1β-Induced IL-6 Upregulation in Temporomandibular Joint Synovium-Derived Mesenchymal Stem Cells

Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage degradation and inflammation. The role of microRNA-24 (miR-24) in the development of temporomandibular joint (TMJ) OA remains unclear. To address this, the ability of miR-24 to attenuate inflammatory responses induced by interleukin-1β (IL-1...

Jia-Dong Sun, Wen-Ting Liao, Fa-Rong Ou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.